A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
<p>Abstract</p> <p>Background</p> <p>Severe hypoglycaemia still represents a significant problem in insulin-treated diabetes. Most patients do not experience severe hypoglycaemia often. However, 20% of patients with type 1 diabetes experience recurrent severe hypoglycae...
Main Authors: | Kristensen Peter, Pedersen-Bjergaard Ulrik, Beck-Nielsen Henning, Nørgaard Kirsten, Perrild Hans, Christiansen Jens, Jensen Tonny, Parving Hans-Henrik, Thorsteinsson Birger, Tarnow Lise |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1472-6823/12/10 |
Similar Items
-
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
by: Rikke Mette Agesen, et al.
Published: (2019-07-01) -
Insulin (Technique) Induced Hypoglycaemia
by: Adlyne Reena Asirvatham, et al.
Published: (2017-05-01) -
Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years
by: Bernardo Mertes, et al.
Published: (2020-04-01) -
Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
by: Peter L Kristensen, et al.
Published: (2016-11-01) -
A systematic review of literature on Insulin‐like growth factor‐2‐mediated hypoglycaemia in non‐islet cell tumours
by: Fateen Ata, et al.
Published: (2024-03-01)